| SMC | smooth muscle cell |
| EndMT | endothelial-to-mesenchymal transition |
| EndIT | endothelial-to-immune cell-like transition |
| TGF-β | transforming growth factor-beta |
| TLRs | toll-like receptors |
| VCAM-1 | vascular cell adhesion molecule-1 |
| ICAM-1 | intercellular adhesion molecule-1 |
| FGF | fibroblast growth factor |
| IFN-γ | interferon-gamma |
| APCs | antigen-presenting cells |
| MHC I | major histocompatibility complex I |
| MHC II | major histocompatibility complex II |
| VE-Cadherin | vascular endothelial-cadherin |
| CD31/PECAM-1 | platelet/EC adhesion molecule-1 |
| vwf | von Willebrand factor |
| α-SMA | α-smooth muscle actin |
| SM22α | smooth muscle protein 22α |
| LDL | low-density lipoproteins |
| LOX-1 | low-density lipoprotein receptor-1 |
| ROS | reactive oxygen species |
| NO | nitric oxide |
| NOX | nicotinamide adenine dinucleotide phosphate (NADPH) oxidase |
| XO | xanthine oxidase |
| EDRF | endothelium-derived relaxing factor |
| IL-1a | interleukin-1a |
| BMP-4 | bone morphogenic protein-4 |
| MCP-1 | monocyte chemotactic protein-1 |
| ET-1 | endothelin-1 |
| Ang-II | angiotensin II |
| TXA2 | thromboxane A2 |
| PGI2 | prostacyclin2 |
| d-flow | disturbed blood flow |
| NFқB | Nuclear Factor Kappa B |
| AP-1 | activator protein 1 |